NXS 5.77% 24.5¢ next science limited

Ann: Zimmer complaint, page-34

  1. 142 Posts.
    lightbulb Created with Sketch. 33
    This isn't a David and Goliath battle it's David and Godzilla...or maybe bigger. ZB's speciality is orthopeadics, right in NXS's currently desired sweetspot. Hate to have to say it, but they're someone you would want to have a good relationship with because they're one of the major players, I think third by revenue in this space 2 or 3 years ago. The largest by revenue was Stryker, and then Depuy Synthes (according to the article below). Interesting article here about the industry and it's ongoing purchasing of much needed tecchnology. DYOR

    https://www.odtmag.com/issues/2019-08-14/view_features/the-2019-top-10-global-orthopedic-device-firms-955005/
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $71.46M
Open High Low Value Volume
25.0¢ 26.0¢ 24.5¢ $30.25K 119.2K

Buyers (Bids)

No. Vol. Price($)
2 75861 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 43775 2
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.